Free Trial

Lunai Bioworks (RENB) Insider Trading & Ownership

Lunai Bioworks logo
$0.16 -0.01 (-7.60%)
Closing price 04:00 PM Eastern
Extended Trading
$0.17 +0.01 (+4.51%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Lunai Bioworks (NASDAQ:RENB) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
0.50%
Number Of
Insiders Buying
(Last 3 Years)
0
Number Of
Insiders Selling
(Last 3 Years)
1
Amount Of
Insider Selling
(Last 3 Years)
$480.58K
Get RENB Insider Trade Alerts

Want to know when executives and insiders are buying or selling Lunai Bioworks stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RENB Insider Buying and Selling by Quarter

Lunai Bioworks Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/29/2024Anderson Wittekind WilliamMajor ShareholderSell1,114$1.30$1,448.20  
7/17/2024Anderson Wittekind WilliamMajor ShareholderSell16,362$1.46$23,888.52  
7/15/2024Anderson Wittekind WilliamMajor ShareholderSell21,954$1.41$30,955.14  
7/11/2024Anderson Wittekind WilliamMajor ShareholderSell14,896$1.51$22,492.96  
7/9/2024Anderson Wittekind WilliamMajor ShareholderSell4,630$1.53$7,083.90  
7/5/2024Anderson Wittekind WilliamMajor ShareholderSell60,000$1.55$93,000.00  
7/3/2024Anderson Wittekind WilliamMajor ShareholderSell50,000$1.51$75,500.00  
7/1/2024Anderson Wittekind WilliamMajor ShareholderSell60,000$1.56$93,600.00  
6/27/2024Anderson Wittekind WilliamMajor ShareholderSell14,671$1.50$22,006.50  
6/25/2024Anderson Wittekind WilliamMajor ShareholderSell20,000$1.58$31,600.00  
6/14/2024Anderson Wittekind WilliamMajor ShareholderSell50,000$1.58$79,000.00  
(Data available from 1/1/2013 forward)

RENB Insider Trading Activity - Frequently Asked Questions

The list of insiders at Lunai Bioworks includes Anderson Wittekind William. Learn more on insiders at RENB.

0.50% of Lunai Bioworks stock is owned by insiders. Learn more on RENB's insider holdings.

The following insider sold RENB shares in the last 24 months: Anderson Wittekind William ($480,575.22).

Insiders have sold a total of 313,627 Lunai Bioworks shares in the last 24 months for a total of $480,575.22 sold.

Lunai Bioworks Key Executives

  • Hon. Mark R. Dybul M.D. (Age 61)
    CEO, Director & Member of HBV Scientific Advisory Board
    Compensation: $764.58k
  • Dr. Francois Binette M.Sc. (Age 60)
    Ph.D., COO and Executive VP for Research & Development
    Compensation: $504.38k
  • Dr. Serhat Gümrükcü
    Co-Founder & Inventor
  • Mr. Simon Tarsh (Age 63)
    Interim Chief Financial Officer
  • Mr. Greg Duczynski Ph.D.
    Senior Vice President for Clinical Operations


This page (NASDAQ:RENB) was last updated on 9/22/2025 by MarketBeat.com Staff
From Our Partners